József Toldi spends much of his time researching Kynurenic acid, Neuroscience, Neuroprotection, Pharmacology and Kynurenine. The various areas that he examines in his Kynurenic acid study include Quinolinic acid, Endocrinology and Kynurenine pathway. József Toldi combines subjects such as Senile plaques and Anatomy with his study of Neuroscience.
The study incorporates disciplines such as Tryptophan Metabolism, Huntington's disease and Mitochondrion in addition to Neuroprotection. In Pharmacology, he works on issues like Glutamate receptor, which are connected to Memantine and Receptor complex. His Kynurenine study is concerned with Biochemistry in general.
József Toldi focuses on Neuroscience, Kynurenic acid, Neuroprotection, Pharmacology and Kynurenine. His Neuroscience study frequently draws connections to other fields, such as Anatomy. His work deals with themes such as Kynurenine pathway and Quinolinic acid, which intersect with Kynurenic acid.
József Toldi works mostly in the field of Kynurenine pathway, limiting it down to concerns involving Glutamatergic and, occasionally, Migraine. As part of the same scientific family, József Toldi usually focuses on Neuroprotection, concentrating on Ischemia and intersecting with Hippocampal formation, Long-term potentiation, Anesthesia and Endocrinology. In his research, Endogeny is intimately related to Excitatory postsynaptic potential, which falls under the overarching field of Pharmacology.
His primary areas of study are Kynurenic acid, Pharmacology, Neuroprotection, Neuroscience and Kynurenine. His Kynurenic acid study combines topics from a wide range of disciplines, such as Kynurenine pathway and Endocrinology. His Pharmacology research incorporates themes from Anesthesia, Electrophysiology, Cortical spreading depression, Pathophysiology and Ischemia.
His research integrates issues of Hydrochloride, Neurodegeneration, Excitotoxicity, Long-term potentiation and Brain ischemia in his study of Neuroprotection. József Toldi interconnects Glutamatergic, Neurotransmission, Pathogenesis and Migraine in the investigation of issues within Neuroscience. His Kynurenine research includes themes of Quinolinic acid, Slice preparation, Water maze and Morris water navigation task.
His primary scientific interests are in Kynurenic acid, Neuroscience, Neuroprotection, Pharmacology and Glutamate receptor. József Toldi has researched Kynurenic acid in several fields, including Quinolinic acid, Calcitonin gene-related peptide and Endocrinology. Neuroscience connects with themes related to Pathogenesis in his study.
His study in Neuroprotection is interdisciplinary in nature, drawing from both Kynurenine pathway and Neurodegeneration. His Pharmacology research includes elements of Kynurenine metabolism, Tryptophan Metabolism, Ischemia and Migraine. His Glutamate receptor study combines topics in areas such as NMDA receptor and Cortical spreading depression.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders
Katalin Sas;Hermina Robotka;József Toldi;László Vécsei;László Vécsei.
Journal of the Neurological Sciences (2007)
Role of kynurenines in the central and peripherial nervous systems
Hajnalka Nemeth;Jozsef Toldi;Laszlo Vecsei.
Current Neurovascular Research (2005)
Activation of the primary motor cortex by somatosensory stimulation in adult rats is mediated mainly by associational connections from the somatosensory cortex.
Tamás Farkas;Zsolt Kis;József Toldi;Joachim R. Wolff.
The role of kynurenines in disorders of the central nervous system: Possibilities for neuroprotection
Eniko Vamos;Arpad Pardutz;Peter Klivenyi;Jozsef Toldi.
Journal of the Neurological Sciences (2009)
Kynurenines, Parkinson's disease and other neurodegenerative disorders: preclinical and clinical studies.
H. Németh;J. Toldi;L. Vécsei.
Journal of Neural Transmission-supplement (2006)
The Janus-face kynurenic acid
Éva Rózsa;Hermina Robotka;László Vécsei;József Toldi.
Journal of Neural Transmission (2008)
β-Amyloid pathology in the entorhinal cortex of rats induces memory deficits: Implications for Alzheimer’s disease
E. Sipos;A. Kurunczi;Á. Kasza;J. Horváth.
Neuroprotective effects of a novel kynurenic acid analogue in a transgenic mouse model of Huntington’s disease
Dénes Zádori;Gábor Nyiri;András Szőnyi;István Szatmári.
Journal of Neural Transmission (2011)
Biphasic reorganization of somatotopy in the primary motor cortex follows facial nerve lesions in adult rats
Jozsef Toldi;Rainer Laskawi;Michael Landgrebe;Joachim R. Wolff.
Neuroscience Letters (1996)
Kynurenines in chronic neurodegenerative disorders: future therapeutic strategies
D. Zádori;P. Klivényi;E. Vámos;F. Fülöp.
Journal of Neural Transmission (2009)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: